| 1 |
Ge R, You S, Zheng D, et al. Global, regional, and national temporal trends of diet-related ischemic stroke mortality and disability from 1990 to 2019 ［J］. Int J Stroke, 2024, 19（6）： 665-675.
|
| 2 |
Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017： a systematic analysis for the Global Burden of Disease Study 2017 ［J］. Lancet, 2019, 394（10204）：1145-1158.
|
| 3 |
GBD 2021 Nervous System Disorders Collaborators. Global, regional,and national burden of disorders affecting the nervous system, 1990-2021： a systematic analysis for the Global Burden of Disease Study 2021 ［J］. Lancet Neurol, 2024, 23（4）： 344-381.
|
| 4 |
Zhou L, Wei Y, Ge Y, et al. Global, regional, and national burden of stroke attributable to extreme low temperatures, 1990-2019： A global analysis ［J］. Int J Stroke, 2024, 19（6）： 676-685.
|
| 5 |
Liu P, Chen Z, Han S, et al. The added effects of cold spells on stroke admissions： differential effects on ischemic and hemorrhagic stroke ［J］.Int J Stroke, 2024, 19（2）： 217-225.
|
| 6 |
Li W, Li H, Lu C, et al. Neglected Mendelian causes of stroke in adult Chinese patients who had an ischaemic stroke or transient ischaemic attack ［J］. Stroke Vasc Neurol, 2024, 9（3）： 194-201.
|
| 7 |
Jiang Y, Cheng S, Shi Y, et al. Subtype-specific association of mitochondrial DNA copy number with poststroke/TIA outcomes in 10 241 patients in China ［J］. Stroke, 2024, 55（5）： 1261-1270.
|
| 8 |
Liu H, Jin A, Pan Y, et al. Trends of sex differences and associated factors in stroke outcomes among patients with acute ischemic stroke：2007 to 2018 ［J］. Neurology, 2024, 102（1）： e207818.
|
| 9 |
Chen Z, Liu J, Wang A, et al. Hemodynamic impairment of blood pressure and stroke mechanisms in symptomatic intracranial atherosclerotic stenosis ［J］. Stroke, 2024, 55（7）： 1798-1807.
|
| 10 |
Han M, Huang K, Shen C, et al. Discordant high remnant cholesterol with LDL-C increases the risk of stroke： a Chinese prospective cohort study ［J］. Stroke, 2024, 55（8）： 2066-2074.
|
| 11 |
Zhang Z, Wang M, Gill D, et al. Association of genetically predicted anxiety and depression with functional outcome after ischemic stroke：a mendelian randomization study ［J］. Neurology, 2024, 103（5）：e209776.
|
| 12 |
Huang JA, Lin CH, Wu MJ, et al. Ten-year follow-up investigation of stroke risk in systemic lupus erythematosus ［J］. Stroke Vasc Neurol,2024, 9（1）： 1-7.
|
| 13 |
Sun D, Nguyen TN, Pan Y, et al. Unsuccessful recanalization versus medical management of patients with large ischemic core ： analysis of the ANGEL-ASPECT randomized trial ［J］. Clin Neuroradiol, 2024,34（2）： 441-450.
|
| 14 |
Zhang P, Huang Z, Xu Y, et al. Endovascular treatment effect in vertebrobasilar artery occlusion patients with posterior circulation Acute Stroke Prognosis Early CT Score （pc-ASPECTS） ＜6 ［J］. J NeuroInterv Surg, 2024： jnis-2024-022115. Online ahead of print.
|
| 15 |
Gao F, Tong X, Jia B, et al. Bailout intracranial angioplasty or stenting following thrombectomy for acute large vessel occlusion in China（ANGEL-REBOOT）： a multicentre, open-label, blinded-endpoint,randomised controlled trial ［J］. Lancet Neurol, 2024, 23（8）： 797-806.
|
| 16 |
Yuan G, Zhang J, Ye Z, et al. Effectiveness and safety of bridging therapy and endovascular therapy in patients with large cerebral infarctions： from ANGEL-ASPECT ［J］. Stroke Vasc Neurol, 2024：svn-2024-003120. Online ahead of print.
|
| 17 |
Han B, Tong X, Raynald, et al. Thrombectomy plus intra-arterial thrombolysis versus thrombectomy for acute large vessel occlusions： a matched-control study ［J］. Clin Neuroradiol, 2024, 34（4）： 871-879.
|
| 18 |
Guo M, Yue C, Yang J, et al. Thrombectomy alone versus intravenous thrombolysis before thrombectomy for acute basilar artery occlusion ［J］.J Neurointerv Surg, 2024, 16（8）： 794-800.
|
| 19 |
Han B, Raynald, Wu Y, et al. Thrombectomy versus combined thrombolysis for acute basilar artery occlusion： a secondary analysis of the ATTENTION trial ［J］. J Neurointerv Surg, 2024： jnis-2024-021678. Online ahead of print.
|
| 20 |
Fu Y, Wang A, Tang R, et al. Sublingual edaravone dexborneol for the treatment of acute ischemic stroke： the TASTE-SL randomized clinical trial ［J］. JAMA Neurol, 2024, 81（4）： 319-326.
|
| 21 |
Chen HS, Cui Y, Wang XH, et al. Clopidogrel plus aspirin vs aspirin alone in patients with acute mild to moderate stroke： the ATAMIS randomized clinical trial ［J］. JAMA Neurol, 2024, 81（5）： 450-460.
|
| 22 |
Guan L, Han S, Johnston SC, et al. Duration of benefit and risk of dual antiplatelet therapy up to 72 hours after mild ischemic stroke and transient ischemic attack ［J］. Neurology, 2024, 103（7）： e209845.
|
| 23 |
Liu T, Wang Y, Zhang K, et al. Optimal duration of dual antiplatelet therapy for minor stroke within 72 hours of symptom onset： a prospective cohort study ［J］. Stroke Vasc Neurol, 2024： svn-2023-002933. Online ahead of print.
|
| 24 |
Zhao W, Li S, Li C, et al. Effects of tirofiban on neurological deterioration in patients with acute ischemic stroke： a randomized clinical trial ［J］. JAMA Neurol, 2024, 81（6）： 594-602.
|
| 25 |
Xie X, Jing J, Meng X, et al. Dual antiplatelet therapy after embolic stroke of undetermined source： a subgroup analysis of the CHANCE-2 trial ［J］. Stroke, 2024, 55（7）： 1739-1747.
|
| 26 |
Meng X, Li S, Dai H, et al. Tenecteplase vs alteplase for patients with acute ischemic stroke： the ORIGINAL randomized clinical trial ［J］.JAMA, 2024, 332（17）： 1437-1445.
|
| 27 |
Xiong Y, Wang L, Pan Y, et al. Tenecteplase versus alteplase for acute ischaemic stroke in the elderly patients： a post hoc analysis of the TRACE-2 trial ［J］. Stroke Vasc Neurol, 2024： svn-2023-003048.Online ahead of print.
|
| 28 |
Xiong Y, Campbell BCV, Schwamm LH, et al. Tenecteplase for ischemic stroke at 4.5 to 24 hours without thrombectomy ［J］. N Engl J Med, 2024, 391（3）： 203-212.
|
| 29 |
Cheng X, Hong L, Churilov L, et al. Tenecteplase thrombolysis for stroke up to 24 hours after onset with perfusion imaging selection： the umbrella phase IIa CHABLIS-T randomised clinical trial ［J］. Stroke Vasc Neurol, 2024, 9（5）： 551-559.
|
| 30 |
Li S, Gu HQ, Li H, et al. Reteplase versus alteplase for acute ischemic stroke ［J］. N Engl J Med, 2024, 390（24）： 2264-2273.
|
| 31 |
Li S, Wang X, Jin A, et al. Safety and efficacy of reteplase versus alteplase for acute ischemic stroke： a phase 2 randomized controlled trial ［J］. Stroke, 2024, 55（2）： 366-375.
|
| 32 |
Gao Y, Jiang L, Pan Y, et al. Immediate- or delayed-intensive statin in acute cerebral ischemia： the INSPIRES randomized clinical trial ［J］.JAMA Neurol, 2024, 81（7）： 741-751.
|
| 33 |
Gong C, Liu C, Wang Y, et al. Effect of statin treatment on clinical outcomes in cardioembolic stroke with endovascular thrombectomy ［J］.J Neurointerv Surg, 2024, 16（9）： 947-954.
|
| 34 |
Yang Q, Guo C, Yue C, et al. Methylprednisolone as adjunct to endovascular thrombectomy for large-vessel occlusion stroke： the MARVEL randomized clinical trial ［J］. JAMA, 2024, 331（10）： 840-849.
|
| 35 |
Zhang R, Liu G, Zhao X, et al. Safety and efficacy of GD-11 in patients with ischaemic stroke： a multicentre, double-blind,randomised, placebo-controlled, phase 2 trial ［J］. Stroke Vasc Neurol,2024： svn-2024-003338. Online ahead of print.
|
| 36 |
Li J, Meng X, Shi FD, et al. Colchicine in patients with acute ischaemic stroke or transient ischaemic attack （CHANCE-3）：multicentre, double blind, randomised, placebo controlled trial ［J］.BMJ, 2024, 385： e079061.
|
| 37 |
Chen T, Chen T, Zhang Y, et al. Bilateral effect of acupuncture on cerebrum and cerebellum in ischaemic stroke patients with hemiparesis： a randomised clinical and neuroimaging trial ［J］. Stroke Vasc Neurol, 2024, 9（3）： 306-317.
|
| 38 |
Li W, Wang S, Liu L, et al. Normobaric hyperoxia combined with endovascular treatment based on temporal gradient： a dose-escalation study ［J］. Stroke, 2024, 55（6）： 1468-1476.
|
| 39 |
Jin Y, Huang YH, Chen YP, et al. Combined effect of cortical superficial siderosis and cerebral microbleed on short-term and longterm outcomes after intracerebral haemorrhage ［J］. Stroke Vasc Neurol, 2024, 9（4）： 429-438.
|
| 40 |
Song L, Cheng J, Zhang C, et al. The frequency of imaging markers adjusted for time since symptom onset in intracerebral hemorrhage： a novel predictor for hematoma expansion ［J］. Int J Stroke, 2024, 19（2）：226-234.
|
| 41 |
Yang D, Luo X, Sun S, et al. Abnormal dynamic functional connectivity in young nondisabling intracerebral hemorrhage patients［J］. Ann Clin Transl Neurol, 2024, 11（6）： 1567-1578.
|
| 42 |
Wu J, Liu Z, Yao M, et al. Clinical characteristics of cerebral amyloid angiopathy and risk factors of cerebral amyloid angiopathy related intracerebral hemorrhage ［J］. J Neurol, 2024, 271（8）： 5025-5034.
|
| 43 |
Yang Y, Li J, Xiao Z, et al. Relationship between stress hyperglycemia ratio and prognosis in patients with aneurysmal subarachnoid hemorrhage： a two-center retrospective study ［J］. Neurosurg Rev,2024, 47（1）： 315.
|
| 44 |
Feng X, Zhang T, Wang N, et al. Safety and efficacy of glibenclamide on cerebral oedema following aneurysmal subarachnoid haemorrhage：a randomised, double-blind, placebo-controlled clinical trial ［J］. Stroke Vasc Neurol, 2024, 9（5）： 530-540.
|
| 45 |
Zhong P, Lu Z, Li Z, et al. Impact of premorbid hypertension and renin-angiotensin-aldosterone system inhibitors on the severity of aneurysmal subarachnoid haemorrhage： a multicentre study ［J］. Stroke Vasc Neurol, 2024： svn-2023-003052. Online ahead of print.
|
| 46 |
Yuan K, Wang K, Zhang H, et al. Nomogram to predict good neoangiogenesis after indirect revascularization surgery in patients with Moyamoya disease： a case-control study ［J］. Transl Stroke Res,2024, 15（5）： 925-935.
|
| 47 |
Zhang X, Lei Y, Su J, et al. Individualised evaluation based on pathophysiology for moyamoya vasculopathy： application in surgical revascularisation ［J］. Stroke Vasc Neurol, 2024, 9（3）： 268-278.
|
| 48 |
Ma H, Gu Y, Bian T, et al. Dabigatran etexilate versus warfarin in cerebral venous thrombosis in Chinese patients （CHOICE-CVT）： An open-label, randomized controlled trial ［J］. Int J Stroke, 2024, 19（6）：635-644.
|
| 49 |
Qiu T, Hong H, Zeng Q, et al. Effect of cerebral small vessel disease on the integrity of cholinergic system in mild cognitive impairment patients： a longitudinal study ［J］. J Neurol, 2024, 271（5）： 2704-2715.
|
| 50 |
Meng Y, Wang S, Zhu W, et al. Association of mean upper cervical spinal cord cross-sectional area with cerebral small vessel disease： a community-based cohort study ［J］. Stroke, 2024, 55（3）： 687-695.
|
| 51 |
Liu Q, Liu P, Zhang Y, et al. Serum interleukin-1 levels are associated with intracranial aneurysm instability ［J］. Transl Stroke Res, 2024,15（2）： 433-445.
|
| 52 |
Lu J, Li Z, Deng H, et al. Treatment modalities and outcomes in brainstem cavernous malformations： a large multicenter observational cohort study ［J］. Stroke, 2024, 55（5）： 1151-1160.
|
| 53 |
Ma Y, Song Z, Wang Y, et al. Clinical features, treatment strategies and outcomes of craniocervical junction arteriovenous fistulas： a cohort study of 193 patients ［J］. Stroke Vasc Neurol, 2024, 9（1）： 18-29.
|